New guidelines and evidence for prevention and treatment of dyslipidemia and atherosclerotic cardiovascular disease in China

Código QR

New guidelines and evidence for prevention and treatment of dyslipidemia and atherosclerotic cardiovascular disease in China

Guardado en:

Detalles Bibliográficos
Autor principal:	Da-Yi Hu
Formato:	article
Lenguaje:	EN
Publicado:	KeAi Communications Co., Ltd. 2017
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/581f842702c04cebb02be2ddbc5e9c55
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Risk stratification of atherosclerotic cardiovascular disease in Chinese adults
por: Xue-Li Yang, et al.
Publicado: (2016)

ESTIMATED AGGREGATE TREATMENT BENEFIT WITH ADDITION OF MULTIPLE NOVEL MEDICATIONS FOR SECONDARY PREVENTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
por: Robert W. Ariss, et al.
Publicado: (2021)

Mass prevention and treatment: Fundamental strategy for chronic disease control and prevention
por: Da-Yi Hu
Publicado: (2016)

Association between circulating oxidized low-density lipoprotein and atherosclerotic cardiovascular disease
por: Shen Gao, et al.
Publicado: (2017)

The gut microbiome in atherosclerotic cardiovascular disease
por: Zhuye Jie, et al.
Publicado: (2017)

Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic Treatment
por: Anne Mirjam Kerola, et al.
Publicado: (2021)

Preventive treatment in migraine and the new US guidelines
por: Estemalik E, et al.
Publicado: (2013)

The association of atherosclerotic cardiovascular disease and statin use with inflammation and treatment outcomes in tuberculosis
por: Vignesh Chidambaram, et al.
Publicado: (2021)

Dyslipidemia and cardiovascular disease risk profiles of patients attending an HIV treatment clinic in Harare, Zimbabwe
por: Zhou DT, et al.
Publicado: (2015)

Cardiovascular disease and nutrition: The use of food-based dietary guidelines for prevention in Africa
por: P.T. Pisa, et al.
Publicado: (2017)

Prevention and treatment of chronic respiratory diseases in China
por: Nan-Shan Zhong, et al.
Publicado: (2019)

Is carotid artery evaluation necessary for primary prevention in asymptomatic high-risk patients without atherosclerotic cardiovascular disease?
por: Kim GH, et al.
Publicado: (2015)

Associations of dipping and non-dipping hypertension with cardiovascular diseases in patients with dyslipidemia
por: Siping Dai, et al.
Publicado: (2019)

Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment
por: Yi-Heng Li, et al.
Publicado: (2020)

Awareness, treatment, control, and determinants of dyslipidemia among adults in China
por: Sampson Opoku, et al.
Publicado: (2021)

Pathways by Which Food Insecurity Is Associated With Atherosclerotic Cardiovascular Disease Risk
por: Deepak Palakshappa, et al.
Publicado: (2021)

Vaccine targeting ANGPTL3 ameliorates dyslipidemia and associated diseases in mouse models of obese dyslipidemia and familial hypercholesterolemia
por: Hirotaka Fukami, et al.
Publicado: (2021)

New insights into the pathological development of dyslipidemia in patients with hypothyroidism
por: Xin Su, et al.
Publicado: (2021)

Interpretation of the 7th edition of the “diagnosis and treatment guidelines of coronavirus disease 2019 in China”: Progress and challenges
por: Li-Xin Xie
Publicado: (2020)

Race/Ethnic and Sex Differences in the Association of Atherosclerotic Cardiovascular Disease Risk and Healthy Lifestyle Behaviors
por: Alanna A. Morris, et al.
Publicado: (2018)

FREQUENCY AND PATTERN OF DYSLIPIDEMIA IN CHILDREN WITH END STAGE RENAL DISEASE
por: Adeela Chaudhry, et al.
Publicado: (2019)

Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science
por: Charles Amir German, et al.
Publicado: (2020)

Is the physician's behavior in dyslipidemia diagnosis in accordance with guidelines? Cross-sectional ESCARVAL study.
por: Antonio Palazón-Bru, et al.
Publicado: (2014)

China's Medium-to-Long Term Plan for the Prevention and Treatment of Chronic Diseases (2017â2025) under the Healthy China Initiative
por: Ling-Zhi Kong
Publicado: (2017)

Amendment of the low-density lipoprotein cholesterol target in the âChinese Guidelines for the Prevention and Treatment of Adult Dyslipidemiaâ: Opinion
por: Shui-Ping Zhao
Publicado: (2016)

Machine learning and atherosclerotic cardiovascular disease risk prediction in a multi-ethnic population
por: Andrew Ward, et al.
Publicado: (2020)

Diet and Lifestyle Factors and Risk of Atherosclerotic Cardiovascular Disease—A Prospective Cohort Study
por: Stefan Acosta, et al.
Publicado: (2021)

Factor H-related protein 1 (FHR-1) is associated with atherosclerotic cardiovascular disease
por: Sarah Irmscher, et al.
Publicado: (2021)

Prevalence of elevated lipoprotein (a) in atherosclerotic cardiovascular disease and its relation to severity of coronary artery disease
por: Abhijeet Kumar, et al.
Publicado: (2021)

Residual Risk Factors to Predict Major Adverse Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients with and without Diabetes Mellitus
por: Fang-Ju Lin, et al.
Publicado: (2017)

A Comprehensive Analysis of the Efficacy of Resveratrol in Atherosclerotic Cardiovascular Disease, Myocardial Infarction and Heart Failure
por: Pema Raj, et al.
Publicado: (2021)

The role of endothelial damage and dyslipidemia in the development of cardiovascular pathology in psoriatic arthritis
por: Zarema R. Khismatullina, et al.
Publicado: (2021)

Clinical considerations of lipid target and goal in dyslipidemia control
por: Na-Qiong Wu, et al.
Publicado: (2016)

Integrative Analysis of Multi-Omics and Genetic Approaches—A New Level in Atherosclerotic Cardiovascular Risk Prediction
por: EIena I. Usova, et al.
Publicado: (2021)

Anti-inflammatory Treatment of Kawasaki Disease: Comparison of Current Guidelines and Perspectives
por: Piotr Buda, et al.
Publicado: (2021)

Molecular Immune-Inflammatory Connections between Dietary Fats and Atherosclerotic Cardiovascular Disease: Which Translation into Clinics?
por: Elisa Mattavelli, et al.
Publicado: (2021)

Progress of research on dyslipidemia accompanied by nephrotic syndrome
por: Min Tao, et al.
Publicado: (2020)

Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascular Diseases
por: Pala R, et al.
Publicado: (2020)

Adiponectin-coated nanoparticles for enhanced imaging of atherosclerotic plaques
por: Almer G, et al.
Publicado: (2011)

The Concept of the Polypill in the Prevention of Cardiovascular Disease
por: Brandon Wiley, et al.
Publicado: (2014)